前收市價 | 115.23 |
開市 | 115.61 |
買盤 | 116.20 x 200 |
賣出價 | 116.72 x 100 |
今日波幅 | 114.68 - 117.05 |
52 週波幅 | 74.75 - 142.00 |
成交量 | |
平均成交量 | 2,843,638 |
市值 | 46.366B |
Beta 值 (5 年,每月) | 1.22 |
市盈率 (最近 12 個月) | 75.71 |
每股盈利 (最近 12 個月) | 1.54 |
業績公佈日 | 2024年7月25日 - 2024年7月29日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 152.63 |
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
Innovation is paying off for both of these medical device specialists.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.